Moreover, studies have proved that kisspeptins exhibit anti-angiogenesis and anti-invasion activity in many malignant tumors, including pancreatic cancer, colorectal cancer and ovarian cancer 13-15. This evidence concerns the gene KISS1 and colorectal cancer.